Search
for

    Sort by

    Research 721–750 of 1000+

    1. Post SARS-CoV-2 vaccination effluvium European Journal of Dermatology · 2022
    2. Asymptomatic SARS-COV2 Infection or COVID-19 vaccination effect for severe multisystem inflammatory syndrome in a 6-year-old girl: case report and review of the literature 2024
    3. Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab Journal of Endocrinological Investigation · 2020 · 198 citations
    4. Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2 Journal of Medical Virology · 2021 · 30 citations
    5. Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19 Journal of infection and chemotherapy · 2021 · 21 citations
    6. Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia Medical Gas Research · 2023 · 13 citations
    7. Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy Dermatology and Therapy · 2021 · 7 citations
    8. Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 7 citations
    9. Telogen effluvium in SARS‐CoV‐2 infection: Histological aspects Journal of the European Academy of Dermatology and Venereology · 2023 · 4 citations
    10. Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 3 citations
    11. Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells PLoS Pathogens · 2022 · 1 citations
    12. Hair loss after SARS-CoV2 Infection Journal of Education, Health and Sport · 2022
    13. Medical education and care in dermatology during the SARS‐CoV2 pandemia: challenges and chances Journal of the European Academy of Dermatology and Venereology · 2020 · 44 citations
    14. Virtual Screening of Potential Inhibitors for SARS-CoV-2 Main Protease 2020 · 8 citations
    15. Natural Products as A Promising Therapy for SARS COV-2; An Overview Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512) · 2021 · 3 citations
    16. The clinical course and outcomes of SARS-CoV-2 virus infection in children: a 24-week follow-up study in Sulaimaniyah, Iraq BMC Pediatrics · 2023 · 1 citations
    17. Computational Screening of Repurposed Drugs Targeting Sars-Cov-2 Main Protease By Molecular Docking Sudan Journal of Medical Sciences · 2022 · 1 citations
    18. Impact of the new corona virus (SARS-CoV-2) pandemic on climateric women’s health: websurvey Maturitas · 2023
    19. MANIFESTAÇÕES CUTÂNEAS CORROBORADAS À INFECÇÃO POR SARS-COV-2 Amplla Editora eBooks · 2022
    20. The role of testosterone in SARS-CoV-2 infection Research Outreach · 2021
    21. Identifying Long-Term Effects of SARS-CoV-2 and Their Association with Social Determinants of Health in a Cohort of Over One Million COVID-19 Survivors Research Square (Research Square) · 2021
    22. Evaluating cepharanthine analogues as natural drugs against SARS-CoV-2 2021
    23. Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 18 citations
    24. Antiviral effects of human placenta hydrolysate (Laennec®) against SARS-CoV-2 in vitro and in the ferret model The Journal of Microbiology · 2021 · 13 citations
    25. Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 <i>in vitro</i> infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19 bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 13 citations
    26. Immunological and virological profile of children with chilblain‐like lesions and SARS‐CoV‐2 Journal of the European Academy of Dermatology and Venereology · 2020 · 9 citations
    27. Riesgo de coagulopatía inducida por sepsis a causa de SARS COV-2 en pacientes en período de gestación Revista Ciencia Multidisciplinaria CUNORI · 2025
    28. CECHY KLINICZNE PRZEBIEGU CHORÓB UKŁADU ODDECHOWEGO WYWOŁANYCH PRZEZ SARS-COV-2 U DZIECI Z ZACHODNICH REGIONÓW BIAŁORUSI Wiadomości Lekarskie · 2024
    29. Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical <i>in silico/in vitro</i> screening methods bioRxiv (Cold Spring Harbor Laboratory) · 2020
    30. Computational screening of repurposed drugs and natural products against SARS-Cov-2 main protease (Mpro) as potential COVID-19 therapies arXiv (Cornell University) · 2020